Akinboro, O., Nair, A., Zendel, L., DeClaro, R. A. M. (2026). Risk evaluation and mitigation strategies for approved oncology drug and non-cellular biologic products from 2008 to 2025: An FDA analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e23029